# A Comparison of PT027 vs PT007 Used as Needed in Participants With Asthma

> **NCT05505734** · PHASE3 · COMPLETED · sponsor: **Bond Avillion 2 Development LP** · enrollment: 2516 (actual)

## Conditions studied

- Asthma

## Interventions

- **DRUG:** BDA MDI
- **DRUG:** AS MDI

## Key facts

- **NCT ID:** NCT05505734
- **Lead sponsor:** Bond Avillion 2 Development LP
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-09-02
- **Primary completion:** 2024-08-22
- **Final completion:** 2024-08-22
- **Target enrollment:** 2516 (ACTUAL)
- **Last updated:** 2025-08-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05505734

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05505734, "A Comparison of PT027 vs PT007 Used as Needed in Participants With Asthma". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT05505734. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*